Antibody patents: Danger ahead for biologics

by John H. Heithaus and Gerald M. Murphy | Life Science IP Review

John Heithaus and Gerald Murphy discuss the evolution of antibody written description standards at the USPTO.  Read more of their article featured in Life Science IP Review.

 

Read the full article here.

 


 

Contact Us

Consent
I consent to BSKB.com collecting and storing my data from this form. (BSKB respects your right to privacy. For more about how we store and use data, please read our Privacy Policy.)